Kodiak Sciences Inc. (KOD)
NASDAQ: KOD · Real-Time Price · USD
23.22
+0.20 (0.87%)
Dec 16, 2025, 1:57 PM EST - Market open
Kodiak Sciences Market Cap
Kodiak Sciences has a market cap or net worth of $1.23 billion as of December 16, 2025. Its market cap has increased by 257.38% in one year.
Market Cap
1.23B
Enterprise Value
1.21B
1-Year Change
257.38%
Ranking
Category
Stock Price
$23.22
Market Cap Chart
Since October 4, 2018, Kodiak Sciences's market cap has increased from $357.63M to $1.23B, an increase of 243.65%. That is a compound annual growth rate of 18.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 15, 2025 | 1.22B | 133.24% |
| Dec 31, 2024 | 522.39M | 228.65% |
| Dec 29, 2023 | 158.95M | -57.33% |
| Dec 30, 2022 | 372.50M | -91.44% |
| Dec 31, 2021 | 4.35B | -41.22% |
| Dec 31, 2020 | 7.40B | 134.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 4, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |